Pastan I - Search Results

1

Targeted cytotoxic therapy kills persisting HIV infected cells during ART.

Denton PW, Long JM, Wietgrefe SW, Sykes C, Spagnuolo RA, Snyder OD, Perkey K, Archin NM, Choudhary SK, Yang K, Hudgens MG, Pastan I, Haase AT, Kashuba AD, Berger EA, Margolis DM, Garcia JV. Denton PW, et al. Among authors: pastan i. PLoS Pathog. 2014 Jan;10(1):e1003872. doi: 10.1371/journal.ppat.1003872. Epub 2014 Jan 9. PLoS Pathog. 2014. PMID: 24415939 Free PMC article.

2

Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis.

McHugh L, Hu S, Lee BK, Santora K, Kennedy PE, Berger EA, Pastan I, Hamer DH. McHugh L, et al. Among authors: pastan i. J Biol Chem. 2002 Sep 13;277(37):34383-90. doi: 10.1074/jbc.M205456200. Epub 2002 Jul 15. J Biol Chem. 2002. PMID: 12119300 Free article.

3

Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques.

Kennedy PE, Bera TK, Wang QC, Gallo M, Wagner W, Lewis MG, Berger EA, Pastan I. Kennedy PE, et al. Among authors: pastan i. J Leukoc Biol. 2006 Nov;80(5):1175-82. doi: 10.1189/jlb.0306139. Epub 2006 Aug 21. J Leukoc Biol. 2006. PMID: 16923920

4

Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs.

Berger EA, Pastan I. Berger EA, et al. Among authors: pastan i. PLoS Pathog. 2010 Jun 10;6(6):e1000803. doi: 10.1371/journal.ppat.1000803. PLoS Pathog. 2010. PMID: 20548940 Free PMC article. No abstract available.

5

Immunotoxins in cancer therapy.

Pastan I, Kreitman RJ. Pastan I, et al. Curr Opin Investig Drugs. 2002 Jul;3(7):1089-91. Curr Opin Investig Drugs. 2002. PMID: 12186272 Review.

6

Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma.

Li Z, Mahesh SP, Shen DF, Liu B, Siu WO, Hwang FS, Wang QC, Chan CC, Pastan I, Nussenblatt RB. Li Z, et al. Among authors: pastan i. Cancer Res. 2006 Nov 1;66(21):10586-93. doi: 10.1158/0008-5472.CAN-06-1981. Cancer Res. 2006. PMID: 17079483 Free PMC article.

7

A recombinant immunotoxin targeting CD22 with low immunogenicity, low nonspecific toxicity, and high antitumor activity in mice.

Hansen JK, Weldon JE, Xiang L, Beers R, Onda M, Pastan I. Hansen JK, et al. Among authors: pastan i. J Immunother. 2010 Apr;33(3):297-304. doi: 10.1097/CJI.0b013e3181cd1164. J Immunother. 2010. PMID: 20445350 Free PMC article.

8

Immunotoxins with decreased immunogenicity and improved activity.

Pastan I, Onda M, Weldon J, Fitzgerald D, Kreitman R. Pastan I, et al. Leuk Lymphoma. 2011 Jun;52 Suppl 2(Suppl 2):87-90. doi: 10.3109/10428194.2011.573039. Epub 2011 Apr 19. Leuk Lymphoma. 2011. PMID: 21504287 Free PMC article.

9

Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy.

Singh R, Zhang Y, Pastan I, Kreitman RJ. Singh R, et al. Among authors: pastan i. Clin Cancer Res. 2012 Jan 1;18(1):152-60. doi: 10.1158/1078-0432.CCR-11-1839. Epub 2011 Nov 8. Clin Cancer Res. 2012. PMID: 22068660 Free PMC article.

10

Mesothelin-targeted agents in clinical trials and in preclinical development.

Kelly RJ, Sharon E, Pastan I, Hassan R. Kelly RJ, et al. Among authors: pastan i. Mol Cancer Ther. 2012 Mar;11(3):517-25. doi: 10.1158/1535-7163.MCT-11-0454. Epub 2012 Feb 17. Mol Cancer Ther. 2012. PMID: 22351743 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,282 results

Search Page

Filters